Zhou, Binhua <br/><br/>
Deubiquitinase inhibition of 19S regulatory particles by 4-arylidene curcumin analog AC17 causes NF-κB inhibition and p53 reactivation in human lung cancer cells.  [electronic resource] 

 -  Molecular cancer therapeutics  Aug 2013 
 - 1381-92 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1538-8514 
<br/><br/><label>Standard No.: </label>10.1158/1535-7163.MCT-12-1057  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Cell Line, Tumor<br/>Cell Proliferation--drug effects<br/>Curcumin--analogs & derivatives<br/>Disease Models, Animal<br/>Enzyme Activation--drug effects<br/>Enzyme Inhibitors--pharmacology<br/>Female<br/>Humans<br/>Lung Neoplasms--drug therapy<br/>NF-kappa B--antagonists & inhibitors<br/>Proteasome Endopeptidase Complex--metabolism<br/>Proteasome Inhibitors--pharmacology<br/>Proteolysis--drug effects<br/>Tumor Burden--drug effects<br/>Tumor Suppressor Protein p53--agonists<br/>Ubiquitin-Specific Proteases--antagonists & inhibitors<br/>Ubiquitination--drug effects<br/>Xenograft Model Antitumor Assays